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A B S T R A C T
Despite extensive research eﬀorts, drug addiction persists as a largely unmet medical need. Perhaps the biggest
challenge for treating addiction is the high rate of recidivism. While many factors can promote relapse in ab-
stinent drug users, the contribution of stress is particularly problematic, as stress is uncontrollable and pervasive
in the lives of those struggling with addiction. Thus, understanding the neurocircuitry that underlies the in-
ﬂuence of stress on drug seeking is critical for guiding treatment. Preclinical research aimed at deﬁning this
neurocircuitry has, in part, relied upon the use of experimental approaches that allow visualization of cellular
and circuit activity that corresponds to stressor-induced drug seeking in rodent relapse models. Much of what we
have learned about the mechanisms that mediate stressor-induced relapse has been informed by studies that
have used the expression of the immediate early gene, cfos, or its protein product, Fos, as post-mortem activity
markers. In this review we provide an overview of the rodent models used to study stressor-induced relapse and
brieﬂy summarize what is known about the underlying neurocircuitry before describing the use of cfos/Fos-
based approaches. In addition to reviewing ﬁndings obtained using this approach, its advantages and limitations
are considered. Moreover, new techniques that leverage the expression proﬁle of cfos to tag and manipulate cells
based on their activity patterns are discussed. The intent of the review is to guide the interpretation of old and
design of new studies that utilize cfos/Fos-based strategies to study the neurocircuitry that contributes to stress-
related drug use.
1. Introduction
Drug addiction persists as a critical public health issue in the United
States that imposes tremendous economic, medical, and social burdens.
As of 2014, an estimated 21.5 million Americans (8.5% of the US po-
pulation; NSDUH) abused illicit drugs. A major challenge to the treat-
ment of drug addiction is its chronically relapsing nature. Despite ad-
vances in understanding the neurobiology of drug addiction, eﬀective
treatment is lacking and the risk for relapse once addicts abstain from
drug use is very high, with some estimates of relapse risk close to 70%,
depending on the abused drug (Brandon et al., 2007; Shah et al., 2006).
Unfortunately, there are few FDA-approved medications for the treat-
ment of substance use disorders (SUDs) and none for psychostimulants,
thus highlighting a crucial unmet need.
The primary triggers for drug craving and relapse are re-exposure to
the abused drug, exposure to drug-associated cues and context, and the
onset of stress. Among these triggers, stress is particularly problematic,
as it is pervasive in the lives of most individuals who are battling
addiction, and, unlike other relapse-inducing stimuli, it is often un-
avoidable in daily life. For this reason, understanding the neuro-
circuitry and neurobiological mechanisms that mediate the contribu-
tion of stress to relapse should guide the development of more eﬀective
relapse prevention therapies and pharmaceutical interventions.
2. Stress inﬂuence on drug and alcohol use: evidence from human
studies
The relationship between stress and SUDs is well-documented
(Sinha, 2009; Sinha et al., 2011). There is a high incidence of stress-
associated neuropsychiatric conditions such as anxiety/mood disorders
in drug-dependent populations (Chen et al., 2011; Rounsaville et al.,
1991); in 2014, about 8 million Americans were diagnosed with both a
mental health disorder and a SUD (SAMHSA). Moreover, there is strong
evidence that stressors can induce craving in SUD populations
(Constantinou et al., 2010; Fox et al., 2008; McRae-Clark et al., 2011;
Sinha et al., 2009, 2006, 1999). Importantly, stressor-induced craving
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or stress reactivity is predictive of later relapse (Back et al., 2009; Sinha
et al., 2006). Additionally, in situations where stress does not directly
trigger craving and relapse, it may promote reactivity to other relapse
triggers, such as drug-associated cues (Furnari et al., 2015; Moran-Santa
Maria et al., 2014; Preston and Epstein, 2011; Preston et al., 2018,
2017, 2009). The neurobiological mechanisms that mediate the con-
tribution of stress to drug-seeking behavior are not well understood.
Thus, studies aimed at better deﬁning the underlying neurocircuitry
and cellular mechanisms are needed.
3. Pre-clinical models of relapse
3.1. Drug self-administration
Pre-clinical rodent models have provided essential information
about the neurocircuitry involved in stressor-induced relapse. One of
the most commonly used models incorporates drug self-administration,
wherein rodents engage in an operant task (e.g., lever pressing or nose
poking), to receive drug delivery. The validity of this model stems
largely from the observation that rodents will voluntarily self-admin-
ister many of the same drugs that are abused by humans, including
psychostimulants, heroin, alcohol, and opiates (Gardner, 2000; Weiss
et al., 1992). Relapse-like behavior can be assessed by measuring the
reinstatement of responding previously reinforced by the drug fol-
lowing a period of extinction training or forced or voluntary abstinence
(Farrell et al., 2018). Many of the same stimuli that induce relapse or
craving in humans have been demonstrated to reinstate drug seeking in
rodents, including non-contingent priming injections of the drug, ex-
posure to drug-associated cues and contexts, and exposure to stressors
(Self and Nestler, 1998; Shaham et al., 2000; Stewart, 2000).
A variety of stressors have been demonstrated to reinstate drug
seeking following self-administration, including uncontrollable electric
footshock (Buczek et al., 1999; Erb et al., 1996; Lê et al., 1998; Shaham
and Stewart, 1995; Shepard et al., 2004), acute food deprivation
(Shalev et al., 2003a,b, 2000), forced swim (Conrad et al., 2010),
pharmacological “stressors” such as yohimbine (Bremner et al., 1996;
Feltenstein and See, 2006; Lê et al., 2005; Shepard et al., 2004) and
corticotropin releasing factor (Erb et al., 2006; Lê et al., 2002; Shaham
et al., 1997), and cues previously paired with social defeat (Funk et al.,
2005). Notably, the complexity of the contribution of stress to drug
seeking in humans can also be captured using the self-administration/
reinstatement approach. Under self-administration conditions where
electric footshock does not directly trigger cocaine seeking following
extinction, it can potentiate reinstatement in response to a sub-
threshold priming dose of cocaine (Graf et al., 2013; McReynolds et al.,
2017, 2016) or drug-associated cues (Buﬀalari and See, 2009;
Feltenstein and See, 2006). Thus, the self-administration/reinstatement
approach can be used to study the mechanisms and pathways that
mediate triggered drug seeking as well as the potentially non-over-
lapping processes through which stress interacts with other stimuli to
promote relapse.
3.2. Conditioned place preference
A second behavioral approach often used to study relapse using
rodents involves conditioned place preference (CPP). CPP involves re-
peatedly pairing one context with non-contingent administration of a
drug while pairing a second context with non-contingent administra-
tion of the drug's vehicle. When given a choice, animals will typically
demonstrate a preference for (i.e., increase the time spent in) the con-
text previously paired with the drug. This preference can be reduced via
extinction training wherein animals are allowed to freely explore all
contexts under drug-free conditions and can be reinstated by various
stimuli, including stressors (Shalev et al., 2002). As is the case with
drug self-administration, a variety of stressors can reinstate drug-in-
duced CPP following extinction, including footshock (Lu et al., 2001,
2000; Sanchez and Sorg, 2001; Wang et al., 2000), forced swim (Carey
et al., 2007; Kreibich and Blendy, 2004; Ma et al., 2007; Redila and
Chavkin, 2008), restraint (Ribeiro Do Couto et al., 2006; Sanchez et al.,
2003), and pharmacological stressors, such as administration of yo-
himbine (Mantsch et al., 2010) or kappa opioid receptor agonists
(Redila and Chavkin, 2008).
3.3. Limitations of rodent models of relapse
Although self-administration and CPP based approaches are com-
monly used to study relapse-related behaviors, they are not without
their limitations (see Mantsch et al., 2016 for more in-depth discus-
sion). For example, most of the experiments that have deﬁned the
neurocircuitry and mechanisms that underlie drug seeking using these
approaches have relied on extinction-induced suppression of drug-
seeking behavior rather than voluntary abstinence. Moreover, most
stressors that have been tested in rodent reinstatement experiments
classify as physical stressors, such as footshock and forced swim, and
may not properly model the type of psychosocial stressors that human
drug users encounter (see Mantsch et al., 2016 for more in-depth dis-
cussion). Nonetheless, despite their limitations, these models have
provided a useful tool for exploration of the neurocircuitry and neu-
robiological mechanisms that contribute to stressor-induced relapse.
4. The neurocircuitry of stressor-induced reinstatement
Research in a number of laboratories, including ours, has focused on
identifying the complex neurocircuitry that underlies the contribution
of stress to drug seeking as deﬁned using the reinstatement approach. A
brief overview of some of the primary neurocircuitry that has been
identiﬁed thus far is summarized in Fig. 1 (Mantsch et al., 2016;
McReynolds et al., 2014b). However, it is important to recognize that,
while putative neurocircuitry has been characterized, the interaction
between stress and motivational/reward systems is highly complex and
not fully deﬁned. Moreover, the ability of stress to engage neuro-
circuitry that mediates drug seeking likely varies with context, biolo-
gical sex, the nature and timing of the stress, and the type of abused
drug. Indeed, this complexity and the gaps in our understanding es-
tablish a need for experimental approaches that deﬁne activity at the
cellular and circuit level that corresponds to stressor-induced drug
seeking. With this in mind, as we discuss some of the basic neuro-
circuitry that has been implicated in stressor-induced drug seeking, we
will also note research needs that can potentially be addressed using
Fos-based approaches.
4.1. Medial prefrontal cortex
The medial prefrontal cortex (mPFC) is ideally positioned to reg-
ulate stressor-induced drug seeking, as it is highly responsive to stress,
interconnected with both stress- and reward-related circuitry, and im-
portant for the control of goal-directed behavior (Cullinan et al., 1995;
Diorio et al., 1993; Gourley and Taylor, 2016; McKlveen et al., 2015;
Oever et al., 2010). Inhibition of the prelimbic region of the mPFC using
either TTX or baclofen/muscimol prevents stressor-induced reinstate-
ment following extinction (Capriles et al., 2003; McFarland et al.,
2004). Although a number of stress-responsive systems converge on the
mPFC, dopaminergic aﬀerents appear to be particularly important, as
antagonism of dopamine D1 receptors in the mPFC blocks stressor-in-
duced reinstatement (Capriles et al., 2003; McFarland et al., 2004;
Sanchez et al., 2003). There are a number of open questions regarding
the contribution of the mPFC to stressor-induced drug seeking. First,
while it is widely assumed that a glutamatergic projection from the
prelimbic cortex to the nucleus accumbens core mediates stressor-in-
duced reinstatement, this has not been conﬁrmed and potential con-
tributions of other cortical output pathways have not been ruled out.
Second, dopamine D1 receptors are expressed on both GABAergic
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interneurons and pyramidal neurons in the mPFC (Santana et al., 2009;
Vincent et al., 1993), and how exactly dopamine regulates these neu-
ronal populations to induce drug seeking is unknown. Moreover, do-
pamine eﬀects in the mPFC are mediated through modulation of neu-
rotransmission (Seamans et al., 2001a, 2001b). The sources of D1
receptor-regulated excitatory and inhibitory inputs that contribute to
drug seeking have not been well-established. Finally, in addition to the
prelimbic cortex, other subregions of the mPFC (e.g., anterior cingulate
and orbital frontal cortex) have been implicated in stressor-induced
reinstatement (Capriles et al., 2003). Characterization of how this in-
terconnected network of cortical subregions responds to stress and
regulates drug seeking is needed.
4.2. Ventral tegmental area
The source of dopamine in the mPFC is neurons that originate in the
ventral tegmental area (VTA), a region that is implicated in both reward
and stress and may serve as an important integration site for these two
processes (Berger et al., 1976; Eden et al., 1987; Moore and Bloom,
1979). As is the case with the prelimbic cortex, inhibition of the VTA
via baclofen/muscimol administration prevents stressor-induced re-
instatement (McFarland et al., 2004). The VTA is a very heterogenous
region, and there is a demonstrated role for glutamatergic (Wang et al.,
2005, 2012) and GABAergic (Blacktop et al., 2016) neurotransmission
in stressor-induced drug seeking. Moreover, the VTA is regulated by a
number of stress-related neuropeptides, including dynorphin (via kappa
opioid receptors) and corticotropin-releasing factor (CRF via CRFR1
and CRFR2 receptors), both of which have been implicated in stressor-
induced reinstatement (Graziane et al., 2013; Polter et al., 2014;
CRF:Blacktop et al., 2011; Chen et al., 2014; Wang et al., 2007). A
challenge to understanding the contribution of the VTA to stressor-in-
duced drug seeking is its heterogeneous nature (Lammel et al., 2014).
The VTA receives glutamatergic and GABAergic aﬀerents from a
number of brain regions (Geisler et al., 2007; Omelchenko and Sesack,
2007), contains both intrinsic interneuron populations and GABAergic
projecting neurons, and sends dopaminergic and non-dopaminergic
projections throughout the brain (Carr and Sesack, 2000a, 2000b;
Margolis et al., 2012; Nair-Roberts et al., 2008; Omelchenko and
Sesack, 2009). Moreover, there is evidence that the responsiveness of
otherwise similar subgroups of VTA neurons to stress is variable. For
example, some VTA dopamine neurons increase their ﬁring rates during
periods of stress, while others are inhibited (Brischoux et al., 2009).
Similarly, it has been reported that stressors can diﬀerentially regulate
VTA dopamine neurons according to their eﬀerent projection ﬁelds
(Deutch et al., 1991; Lammel et al., 2014). Deﬁning which VTA
aﬀerents relay relevant stress-related signals to the VTA and under-
standing which VTA neuronal populations and output pathways are
activated to promote drug seeking continue to represent important re-
search questions that can be informed by imaging-based approaches.
4.3. Extended amygdala
The extended amygdala, a complex of structures comprised of the
bed nucleus of the stria terminalis (BNST), central amygdala (CeA), and
NAc-shell, is critical for processing and integrating stress-related in-
formation and plays a role in stressor-induced drug seeking (Koob,
2009; McFarland et al., 2004). The structures that make up the ex-
tended amygdala receive dense noradrenergic innervation from the
locus coeruleus (LC) and/or medullary cell groups and are highly in-
terconnected with the mesocorticolimbic system (Koob, 2008; Mantsch
et al., 2016). Although each of these brain regions sends projections to
the VTA (Briand et al., 2010), research has focused largely on the
contribution of the BNST to stressor-induced relapse. For this reason,
we will focus primarily on the role of the BNST, as an example of a
structure in the extended amygdala, in stressor-induced reinstatement.
The BNST is an anatomically complex collection of interconnected
subnuclei, some of which are reciprocally connected with the meso-
corticolimbic system (Vranjkovic et al., 2017). Sub-regions of the BNST
have been implicated in stressor-induced drug seeking (Erb and
Stewart, 1999; Vranjkovic et al., 2014; Wang et al., 2006). The BNST is
heavily regulated by noradrenaline released from projections that
comprise the ventral noradrenergic bundle and arise from medullary
cell groups (Aston-Jones et al., 1999). Noradrenergic regulation of the
BNST is complex and involves α- and β-adrenergic receptors located at
both pre- and post-synaptic sites and the stimulation of local CRF re-
lease (Vranjkovic et al., 2017). In particular, β2-adrenergic receptor
signaling within the ventral lateral BNST and its regulation of CRF-re-
leasing projections to the VTA appears to be critical for stressor-induced
reinstatement (Mantsch et al., 2016; McReynolds et al., 2014a).
Despite our understanding of the contribution of the BNST to
stressor-induced drug seeking, there are a number of outstanding re-
search questions. First, the exact phenotype of the BNST-VTA projection
that promotes drug seeking is not known. Second, although there is
some evidence that a pathway from the CeA to the BNST is important
(Erb et al., 2001) the sources of aﬀerent projections into the BNST that
are regulated by stress to induce drug seeking are poorly understood.
Third, our understanding of the contribution of the complex micro-
circuitry and heterogenous cell populations within the BNST, as well as
the roles of other neuromodulators and neuropeptides to stressor-in-
duced drug seeking is very limited. While the BNST is a good example
Fig. 1. Basic neurocircuitry of stressor-induced reinstate-
ment. Stressor-induced reinstatement requires corticotropin-
releasing factor (CRF), via activation of CRFR1, and nora-
drenergic signaling, via activation of β2-adrenergic receptors,
in the bed nucleus of the stria terminalis (BNST). CRF in the
BNST may arise from the local release of CRF or CRF-con-
taining aﬀerent projections from the central nucleus of the
amygdala (CeA). The BNST then sends CRF-containing ef-
ferent projections to the ventral tegmental area (VTA) where
activation of CRFR1 is critical for stressor-induced reinstate-
ment. The VTA is further regulated by aﬀerent GABAergic
projections from the nucleus accumbens (NAc) shell and
sends important dopaminergic projections to the medial
prefrontal cortex (mPFC). The mPFC then sends a glutama-
tergic projection to the nucleus accumbens core that is ne-
cessary for stressor-, drug-, and drug-associated cue-induced
reinstatement.
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of a structure in the extended amygdala with a demonstrated role in
stressor-induced reinstatement, it is important to note that both the CeA
and the nucleus accumbens shell are also regulated by stress, send
projections to the VTA and have been implicated in stressor-induced
drug seeking (McFarland et al., 2004; Shaham et al., 2000). Further
investigation of how these regions contribute to stressor-induced re-
lapse is needed.
4.4. Summary
Here we have provided a basic overview of some of the neuro-
circuitry that mediates stressor-induced drug seeking. It is important to
note that there are a number of other structures that have been im-
plicated in stressor-induced reinstatement that are not discussed in
detail in the current review including the lateral habenula, lateral hy-
pothalamus, ventral pallidum, dorsal/medial raphe nuclei, and insular
cortex. It is also clear that we still have much to learn about the neu-
rocircuitry and neurobiological mechanisms that underlies the inﬂu-
ence of stress on drug seeking. The remainder of this review will focus
on the methodological tools that are available as we further deﬁne the
neurobiological processes already implicated in stressor-induced drug
seeking and identify novel contributing neurocircuits and pathways.
5. Methodological tools used to identify relevant neurocircuitry
The neurocircuitry involved in stressor regulation of drug-seeking
behavior has traditionally been deﬁned using two complementary ap-
proaches: 1) disrupting the function of circuits; and/or 2) imaging the
activity of circuits during or after relevant behaviors.
5.1. Functional manipulations
Historically, the most widely used method to manipulate pathway
function is behavioral pharmacology. For example, bilateral, site-spe-
ciﬁc intracranial administration of the combination of the GABAergic
agonists, baclofen and muscimol, or of sodium channel blockers, such
as local anesthetics, or tetrodotoxin (TTX), can be used to reversibly
inactivate regions of interest prior to reinstatement testing. Likewise, in
situations where ligand and receptor systems have already been iden-
tiﬁed, drugs that interfere with speciﬁc signaling systems (e.g., an-
tagonists or inhibitors) can be administered intracranially. To draw
conclusions regarding the involvement of pathways in drug seeking,
pharmacological disconnection approaches can be applied. Using this
approach a pathway is inactivated at its upstream source in one
hemisphere and its downstream destination in the other hemisphere
resulting in bilateral inhibition of the pathway of interest. This tech-
nique is useful when there is minimal decussation and unilateral acti-
vation of the pathway is suﬃcient for behavior, as the control condition
is ipsilateral inactivation. This approach is valuable in identifying the
role of speciﬁc signaling mechanisms within the general circuits in-
volved in stressor-induced reinstatement.
More recently, some of the limitations of behavioral pharmacology
to directly test the functional relevance of neurocircuitry involved in
stressor-induced reinstatement have been overcome by newer tech-
nology such as optogenetics and chemogenetics. Both techniques in-
volve the viral or genetically encoded expression of non-native re-
ceptors. In the case of optogenetics, this involves the expression of
opsins, which are light-gated ion channels that are activated by speciﬁc
wavelengths of light. (Fenno et al., 2011). Most commonly, the use of
chemogenetics involves the expression of DREADDs (Designer Re-
ceptors Exclusively Activated by Designer Drugs), G-protein coupled
receptors (hM4Di, hM3Dq, hM3Ds, KORDi) that are activated by bio-
logically inert compounds (Rogan and Roth, 2011). However, there are
other chemogenetic tools available, including expression of hM4Di that
is predominantly traﬃcked to the axon, G-protein-coupled receptors
that are biased towards β-arrestin signaling, ligand-gated ion channels,
and cell-type-speciﬁc pharmacology (Atasoy and Sternson, 2018). The
advantage of these techniques is the superior spatial resolution and the
ability to express these receptors in cell type- and pathway-speciﬁc
manners. This is accomplished through recombination-dependent ex-
pression of the receptors coupled with transgenic or viral expression of
Cre recombinase under the control of cell type-speciﬁc promoters or
through retrograde delivery (Mahler et al., 2014; Smith et al., 2016).
Optogenetics provides superior temporal resolution through tempo-
rally-limited periods of activation/inactivation of opsins (Fenno et al.,
2011) making this technique optimal for discrete behaviors. By con-
trast, chemogenetics provides a useful alternative as activation/in-
activation of circuits with DREADDs occurs over longer time periods
with a single treatment that can be administered systemically (Rogan
and Roth, 2011). Though there are some issues with the widely used
agonist, clozapine-N-oxide (CNO; Gomez et al., 2017; Mahler and
Aston-Jones, 2018), there are other commercially available agonists
that may mitigate some of the concerns surrounding CNO use (Chen
et al., 2015). Both technologies have been critical to the characteriza-
tion of the neurocircuitry involved in stress-related drug use.
5.2. Imaging neuronal activation
While informative, the manipulation of circuits through either
pharmacological or genetic approaches does not necessarily permit
determination of the physiological processes that are engaged during,
and therefore may encode, drug seeking. Therefore, it is often useful to
image the activity of circuits during or after behavior. One primary
method is in vivo electrophysiology, which allows for the examination
of real time changes in either single unit or population activity within a
given brain region in an awake, behaving animal. Traditionally this
technique does not conclusively provide information about the phe-
notypes of the cell populations that drive changes in activation patterns
though novel approaches combining cell-type optogenetic stimulation
and in vivo electrophysiology mitigate some of those limitations (Roux
et al., 2014). Furthermore, there are technical challenges in using this
technique to examine circuit activity during reinstatement in response
to a variety of stressors including electric footshock and forced swim.
A complementary approach that has been used to assess circuit
activation involves ex vivo assessment of immediate early gene (IEG)
activation. Although the development of new calcium imaging-based
techniques holds much promise for in vivo assessment of circuit activity,
most investigation of cellular and pathway function associated with
stressor-related drug seeking has utilized this approach. Although as-
sessed ex vivo in sections of brain, the temporal proﬁle of IEG expression
allows scientists to draw conclusions regarding activity patterns asso-
ciated with discrete in vivo manipulations. IEGs and their protein pro-
ducts are expressed rapidly following neuronal activity, with mRNA
levels detected as early as 5min and their protein product detected as
early as 15–30min, depending on the IEG (Kovács, 2008). There are
several IEGs with diﬀerential time courses for activation and selective
cellular localization which provides multiple options when designing
experiments, though cfos and Fos expression are the most widely used
indicators of neuronal activation. For this reason, the remainder of the
review will focus on approaches using Fos expression to image neuronal
activation by discussing the activation of neurocircuitry by stress in
drug and non-drug experienced animals, advantages and disadvantages
of using the Fos imaging approach, and, ﬁnally, the use of novel ap-
proaches to Fos imaging, and genetic tools using the cfos promoter.
6. Stress-associated neurocircuitry: evidence from Fos imaging
A number of stressors known to reinstate drug seeking also increase
Fos in brain regions implicated in drug-seeking behavior, although
much of the work to date has been conducted in drug-naïve animals.
These brain regions, many of which are included in the putative neu-
rocircuitry for stressor-induced reinstatement as described in Section 4,
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include the mPFC, dorsal and ventral BNST, dorsal hippocampus, locus
coeruleus, paraventricular nucleus of the hypothalamus, and dorsal
raphe nuclei, all of which show increased cfos or Fos expression fol-
lowing exposure to multiple reinstating stressors, including forced swim
(Briand et al., 2010), electric footshock (Funk et al., 2006, 2003),
30 min restraint (Funk et al., 2006), and systemic administration of
yohimbine (Calu et al., 2013; Funk et al., 2006). However, stressor-
speciﬁc patterns of activation are known. For example, while forced
swim (Briand et al., 2010) and yohimbine administration (Funk et al.,
2006) increase nucleus accumbens cfos expression, 30min restraint
does not (Funk et al., 2006). Furthermore, increases in cfos expression
in the nucleus accumbens shell, but not core, are observed following
footshock administration (Funk et al., 2006). It is likely that, in many
cases, these diﬀerential patterns of activation reﬂect the nature of the
stressor, i.e., physical vs psychosocial vs pharmacological. However,
diﬀerences in Fos activation may also reﬂect diﬀerences in stressor
intensity. This is supported by a recent ﬁnding that stressors varying in
intensity, such as open ﬁeld, cat odor, or immobilization stress, elicit
diﬀerential patterns of Fos activation throughout the brain. Úbeda-
Contreras et al. (2018) identiﬁed unique patterns of cfos expression
that, in some cases, exhibited either a positive or negative relationship
with the intensity of the stressor, as assessed by plasma adrenocorti-
cotropic hormone (ACTH) levels, or, in other cases, showed patterns of
expression that were independent of stressor intensity. Recognizing
which activation responses generalize across stressors and which are
stressor-speciﬁc is important when interpreting studies aimed at de-
ﬁning neurocircuitry that contributes to stressor-induced relapse.
It is well-established that drug addiction is associated with wide-
spread neuroadaptations that emerge with repeated drug use. For ex-
ample, consistent with reports that stress reactivity and craving induced
by stress imagery is higher in high-frequency vs. low-frequency cocaine
users (Fox et al., 2005), stressor-induced reinstatement in rats is
heightened following high-intake, long-access cocaine self-administra-
tion compared to lower-intake short-access self-administration
(Mantsch et al., 2008). For this reason, while much information about
stress-related circuitry has been obtained from studies using drug-naïve
animals, it is important to understand how that neurocircuitry may
diﬀer in animals with drug experience.
While some studies have failed to demonstrate that stressor-induced
cfos or Fos expression is diﬀerent in subjects with a history of drug
exposure (Briand et al., 2010), most studies have identiﬁed brain re-
gions that display diﬀerential activation in drug-experienced compared
to drug-naïve animals. Examples of stress-induced Fos activation in
drug-experienced, but not drug-naïve, animals include Fos activation in
the CeA in response to footshock following chronic cocaine injections
(Erb et al., 2004), in the VTA in response to footshock following mor-
phine CPP (Ma et al., 2008), and in the prelimbic cortex in response to
acute food deprivation following heroin SA (Shalev et al., 2003a, 2000).
Furthermore, even when some Fos activation is observed in drug-naïve
animals, this response to stress may be greater in drug-experienced
animals. For example, electric footshock increases Fos expression in
several stress- and reward-related brain regions to signiﬁcantly greater
levels in rats with a history of ethanol self-administration than in
ethanol-naïve rats (Zhao et al., 2006). This is further supported by
studies examining cue-induced reinstatement, in which animals with a
history of cocaine SA display higher cue reactivity, as assessed by
greater Fos activation, in several key brain regions, than drug-naïve
animals (Bastle et al., 2012; Kufahl et al., 2009). The eﬀects of prior
drug exposure on stressor-induced Fos responses also appears to be
brain region-dependent. For example, the BNST, a region that is critical
for stressor-induced reinstatement, is consistently activated following
stress regardless of drug history (Erb et al., 2004; Ma et al., 2008;
Shalev et al., 2003b; Zhao et al., 2006). More work is needed to re-
concile diﬀerences in regional activation depending on drug history to
identify how neurocircuitry involving stress- and reward-related brain
regions can be modiﬁed by drug experience to promote drug-seeking
behavior. Surprisingly, although cfos/Fos imaging has signiﬁcantly
advanced our understanding of the neurobiology that underlies
stressor-induced relapse, there are still relatively few studies inter-
rogating relevant neurocircuitry using these approaches.
The neurocircuitry involved in stressor-induced reinstatement of
drug seeking as identiﬁed by Fos activation is generally supported by
human neuroimaging studies. For example, studies using functional
magnetic resonance imaging (fMRI) have shown that exposure to per-
sonalized stress imagery increases activation of the caudate and dorsal
striatum, as deﬁned by an increase in the blood oxygen level-dependent
(BOLD) signal, in cocaine-dependent individuals and this increase is
associated with stress-induced cocaine craving (Sinha et al., 2005).
Additionally, exposure to personalized stress imagery results in in-
creased activation of corticostriatal-limbic circuitry, such as amygdala,
caudate-putamen, insula, and anterior cingulate cortex, in cocaine-de-
pendent women compared to healthy controls (Potenza et al., 2012).
Furthermore, positron emission tomography (PET) studies using [11C]
Raclopride have identiﬁed increases in dopamine signaling, and a po-
sitive relationship between dopamine signaling and plasma cortisol
levels, in the ventral striatum following an amphetamine challenge with
or without psychosocial stress (Oswald et al., 2005; Wand et al., 2007).
However, there are also clear diﬀerences in regional activation as
identiﬁed by human neuroimaging studies or by rodent Fos activation
studies. This is most clear in studies examining the prefrontal cortex. As
noted above, stress increases Fos activation in the medial prefrontal
cortex of drug-experienced and drug-naïve rodents (Cullinan et al.,
1995; Funk et al., 2003; Shalev et al., 2003a,b; Funk et al., 2006; Briand
et al., 2010; Schank et al., 2015). In contrast, human neuroimaging
studies have consistently identiﬁed decreased regional cerebral blood
ﬂow or BOLD signal in various subregions of the prefrontal cortex, such
as the anterior cingulate cortex (ACC) and ventromedial prefrontal
cortex (vmPFC), in response to stress in cocaine- or alcohol-dependent
individuals compared to healthy controls (Drexler et al., 2000; Seo
et al., 2013; Sinha et al., 2005; Zakiniaeiz et al., 2017) though these
patterns may diﬀer in cocaine-dependent women (Potenza et al., 2012).
However, it should be noted that the BOLD signal may not reﬂect
overall increased activation of a given brain region as it is not possible
to determine whether the BOLD signal is being driven by excitatory or
inhibitory neurons (Lauritzen et al., 2012). More work is needed to
understand what patterns of the BOLD signal mean for excitation/in-
hibition within a given brain region and to understand how identiﬁed
neuronal activation patterns within rodents may inform human drug
abuse studies.
7. Utility and caveats of using Fos as a neuronal activity marker
7.1. The immediate early gene cfos
As with any technique, it is necessary to understand the utility and
limitations of using Fos as an activity marker to identify relevant neu-
rocircuitry. For this reason, discussion of the advantages and dis-
advantages of this approach is provided below. The immediate early
gene cfos, and its protein product Fos, have been used as activity
markers for almost 30 years, and cfos was one of the ﬁrst identiﬁed
immediate early genes (IEGs). The major function of Fos protein results
from the formation of a heterodimer, via its leucine zipper motif, with
members of the Jun protein family to create an inducible transcription
factor, activating-protein 1 (AP1), that is involved in the transduction of
“later” genes (Curran and Franza, 1988; Morgan and Curran, 1991). Fos
is expressed in most cell types in the central nervous system including
GABAergic medium spiny neurons and interneurons, glutamatergic,
spinal cord, monoaminergic, and neurosecretory neurons (Ceccatelli
et al., 1989; Chan et al., 1993; Deutch et al., 1991; Dragunow and
Robertson, 1987; Dragunow et al., 1987; Hoﬀman et al., 1993; Hunt
et al., 1987; Leslie et al., 1993; Menétrey et al., 1989; Morgan et al.,
1987; Robertson et al., 1992; Szekely et al., 1987). Fos is also expressed
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in glia (Condorelli et al., 1989; Dragunow and Robertson, 1988b) and
astrocytes (Arenander et al., 1989; Hisanaga et al., 1990; McNaughton
and Hunt, 1992) though the regulation and function of Fos in these cell
types likely diﬀers from that in neurons. For example, depolarization-
inducing stimuli that elicit Fos activation in neurons do not induce Fos
in astrocytes (Hisanaga et al., 1990). Instead, Fos activation in astro-
cytes and glia may be the result of cellular mechanisms and signaling
involved in diﬀerentiation and proliferation of astrocytes, particularly
following injury (Dragunow et al., 1990; Hisanaga et al., 1990).
Under basal conditions, cfos mRNA and protein are expressed at
very low, barely detectable, levels (Hughes et al., 1992) in most, but not
all, brain regions. However, cfos and Fos are rapidly induced in re-
sponse to various stimuli, including peripheral mechanical and elec-
trical stimulation, pain, inﬂammation, stress, neuroendocrine and
neuropeptide signaling, neuronal depolarization, neurotrophic factors,
neurotransmitters, and increases in intracellular Ca2+ levels (Doucet
et al., 1990; Gaiddon et al., 1996; Ghosh et al., 1994; Greenberg and
Ziﬀ, 1984; Morgan and Curran, 1989; Sheng and Greenberg, 1990;
Sheng et al., 1990; Szekely et al., 1987). Following induction, Fos
protein primarily accumulates in the nucleus (Condorelli et al., 1989;
Dragunow and Robertson, 1988a). The time course of cfos mRNA and
protein expression has been established wherein mRNA levels peak
between 30 and 60min and protein levels peak between 1 and 3 h
following an acute challenge and this expression returns to low, barely
detectable levels within 4–6 h (Chan et al., 1993; Cullinan et al., 1995;
Ding et al., 1994; Ikeda et al., 1994; Kovács and Sawchenko, 1996;
Sonnenberg et al., 1989). However, it should be noted that there are
exceptions to this time course of expression including delayed or pro-
longed patterns of cfos activation in various brain regions following
acute stressors (Cullinan et al., 1995). The low basal level, rapid in-
duction, and transient nature of cfos mRNA and protein expression
ideally positions Fos as an activity marker, especially in comparison to
other IEGs with longer expression patterns, such as zif268 (Cullinan
et al., 1995).
7.2. Utility of the Fos imaging approach
Because cfosmRNA and protein are easy to study and widely used as
activity markers, there are a number of studies across which compar-
isons can be made, assuming the use of the same animal age, sex,
species, strain, and time points for quantiﬁcation of expression. The
primary methods used to visualize and analyze cfos mRNA (in situ hy-
bridization), and Fos protein expression (immunohistochemistry), give
superb spatial resolution, including analysis of laminar patterns of ex-
pression and sub-region speciﬁcity in highly heterogenous brain re-
gions. Furthermore, taking advantage of the well-established time
course for expression patterns, and the accumulation of Fos protein in
the nucleus, a major utility in examining IEG activation is co-localizing
the Fos signal with other cellular markers, including those that are cell
type-speciﬁc, and retrograde tracers (Fig. 2). The ability to concurrently
assess Fos protein with cfos mRNA or other IEGs allows examination of
activation patterns in response to two diﬀerent experimental manip-
ulations by exploiting the diﬀerential time course and location of
mRNA and protein expression. The half-life of cfos mRNA is approxi-
mately 15min (Herdegen and Leah, 1998) and therefore cfos mRNA
should return to basal levels when examining expression at a time point
chosen for peak protein levels. Therefore, it is possible to, at the same
time point, combine immunohistochemistry for nuclear Fos protein
expression, which would correspond to earlier exposure to one sti-
mulus, and in situ hybridization for cytosolic cfos mRNA expression,
which would correspond to later exposure to a diﬀerent stimulus
(Kovács, 2008; Kovács et al., 2001). For example, a newer, optimized
method to concurrently visualize cfos mRNA and Fos protein in the
same tissue, tyramide-ampliﬁed immunohistochemistry-ﬂuorescence in
situ hybridization (TAI-Fish), has been used to identify diﬀerential
neuronal activation in response to appetitive and aversive stimuli in the
same animal (Xiu et al., 2014). A similar version of this technique ca-
pitalizes on diﬀerential temporal and spatial patterns of IEG mRNA
expression termed cellular compartment analysis of temporal activity
by ﬂuorescence in situ hybridization (catFISH; Guzowski et al., 1999;
Vazdarjanova et al., 2002).
As noted above, Fos expression can be co-localized with cell type-
speciﬁc markers to characterize diﬀerential patterns of neuronal acti-
vation following an experimental manipulation. This is especially
powerful as it allows comparison of patterns of activity in diﬀerent cell
types within the same brain region which is particularly useful when
examining heterogenous areas such as the ventral tegmental area. In
particular, this approach has been used to distinguish activation of
dopaminergic, noradrenergic, glutamatergic and GABAergic neurons
following various experimental manipulations (Deutch and Duman,
1996; Ishida et al., 2002a, 2002b; 2001; Ruskin and Marshall, 1997).
As an example, our lab has used the co-localization approach to
identify cell populations in the VTA that are likely involved in the
stressor-induced reinstatement of extinguished cocaine seeking. In this
study, animals with variable cocaine self-administration history (2 or
6 h SA/day; 0.5 mg/kg/inf), underwent extinction training wherein
lever responding decreased as cocaine was no longer available. After
reaching extinction criteria (< 15 lever presses/2 h), a reinstatement
test was given during which a series of intermittent electric footshocks
(each footshock: 3 × 0.5 mA, 200 msec duration; average frequency
45 s) was administered over a 15-min period in the self-administration
context followed by the reinstatement session wherein lever presses
were recorded. Ninety minutes into the reinstatement session, rats were
transcardially perfused with 4% PFA and 25-μm sections were taken at
the level of the VTA. Sections were processed via im-
munohistochemistry for expression of tyrosine hydroxylase and Fos
with a nickel 3,3′-diaminobenzidine (NiDAB)/3,3′-diaminobenzidine
(DAB) stain and the number of VTA dopamine neurons, as deﬁned by
TH-expression, that also expressed Fos was calculated. We found that
the number of TH/Fos + VTA neurons was positively correlated with
cocaine seeking (Fig. 3), suggesting that the activation of dopaminergic
neurons in the VTA likely contributes to stressor-induced reinstatement.
Similar approaches have been used to demonstrate that restraint
stressor-induced reinstatement following cocaine CPP is associated with
increased activation of oxytocin neurons in the lateral hypothalamus
(Tung et al., 2016) and that yohimbine-induced reinstatement fol-
lowing ethanol self-administration results in increased activation of
CRF-, dynorphin- and GABA-positive neurons in the central nucleus of
the amygdala (Walker et al., 2017).
Lastly, we and others use co-localization of Fos protein expression
and a retrograde tracer to identify relevant neurocircuitry involved in
stress and addictive behaviors. Retrograde tracers, such as ﬂuorogold,
cholera toxin subunit B (CTb), red and green retrobeads and retrograde
viral constructs, are infused into target brain regions, taken up by the
axon terminals in that region and transported back to the cell bodies
(Köbbert et al., 2000). The tissue is then analyzed for Fos expression,
retrograde tracer expression, and co-localization of Fos with the retro-
grade tracer (Fig. 2) with higher percentages of co-localized neurons
indicating greater activation of that particular pathway (Mahler and
Aston-Jones, 2012). As an example of this approach, using ﬂuorogold
injections into the VTA, Briand et al. (2010) demonstrated that forced
swim-induced reinstatement following cocaine CPP is associated with
increased activation of vBNST, dBNST, lateral hypothalamus, and in-
fralimbic cortical aﬀerents to the VTA.
Notably, depending on the availability of antibodies or genetically
encoded reporters, it is possible to triple-label brain tissue to identify
co-localization of Fos, a cell-speciﬁc marker, and a retrograde tracer to
examine activation of cell type-speciﬁc pathways, such as dopaminergic
projections from the ventral tegmental area. Furthermore, the newer
retrograde tracers, including Alexa ﬂuor-conjugated CTb and retro-
grade viral constructs expressing diﬀerent fusion proteins, and red and
green retrobeads, enable analysis and comparison of activation of
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multiple pathways within the same animal. One of the strongest ad-
vantages of using Fos as an activity marker is to co-localize expression
with these diﬀerent markers to obtain cell type- and pathway-speciﬁc
patterns of activation during behavior which, until recently with the
development of newer in vivo imaging approaches, has not been fea-
sible. Furthermore, unlike in vivo electrophysiology and the newer in
vivo imaging approaches, Fos imaging is not limited to a single brain
region and it is possible to examine expression patterns throughout the
whole brain. These approaches are relatively simple, fairly inexpensive,
and provide a lot of information from a single animal, thus positioning
Fos imaging as a useful ﬁrst-pass approach to identifying activated
brain regions and pathways following behavior.
Fig. 2. Utility of Fos imaging approaches. There are multiple approaches to using Fos as an activity marker and each approach provides diﬀerent levels of information
as detailed below. A) Fos protein expression is predominantly localized to the nucleus (red circles). Fos is expressed in multiple cell types, including GABAergic and
glutamatergic neurons, and examination of Fos expression alone will identify multiple cell types and multiple projection targets. B) One method to identify unique
patterns of neuronal activation is to co-localize the Fos signal (red) with a cell type-speciﬁc marker (green), such as a marker for glutamatergic neurons. Therefore, it
is possible to identify neuronal activation of a particular cell type via comparison of the number of neurons that express both Fos and the cell-type speciﬁc marker.
However, this method still does not provide information about selective activation of eﬀerent projections. C) To identify activation of speciﬁc pathways, a retrograde
tracer can be used. The retrograde tracer is micro-infused into a speciﬁc projection target, is taken up by the axon terminals and is transported back to the cell body. It
is possible to then to quantify the co-localization of the retrograde tracer signal (blue) and Fos expression (red) to analyze the pattern of pathway activation. It should
be noted that in regions where projection neurons are comprised of multiple cell-types, this method only identiﬁes activation of the speciﬁc pathway independent of
cell type. To obtain information about cell type- and pathway-speciﬁc neuronal activation, it would be necessary to use both a retrograde tracer and a cell type-
speciﬁc marker in combination with Fos expression. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of
this article.)
Fig. 3. Stressor-induced reinstatement of cocaine seeking
is positively correlated with activation of ventral teg-
mental area (VTA) dopamine neurons. A) Electric foot-
shock induces signiﬁcant reinstatement of cocaine
seeking, as deﬁned by an increase in the number of lever
responses during the reinstatement test as compared to
extinction responding, in rats with a variable history of
self-administration (2/hr or 6/hr access/day; t
(19)=−3.67, p < .05). Data are presented as
mean ± SEM. B) Representative image depicting the
area within which immunoreactive cells were counted (at
−6.0 mm from Bregma). C) The number of cells that were
positive for both tyrosine hydroxylase (TH) and Fos ex-
pression in the VTA is positively correlated with the
magnitude of stress-induced reinstatement (p < .05). D)
Representative image of a TH-positive neuron in the VTA.
E) Representative image of a Fos-positive neuron in the
VTA. F) Representative image of a TH/Fos-positive
neuron in the VTA.
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7.3. Caveats to using Fos as a neuronal activity marker
Fos imaging is a useful tool, but there are several limitations and
caveats to consider when applying this approach. First, while it is
possible to gain insight into neuronal activation from increases in Fos
expression, it is important to be careful about interpreting null ﬁndings,
as the absence of changes in Fos expression does not preclude the
presence of relevant changes in neuronal activity. This is best demon-
strated by the observation that there are diﬀerential patterns of basal
expression of IEGs (Cullinan et al., 1995) and diﬀerential patterns of
IEG activation following a stimulus wherein increases in other IEGs,
such as arc, c-jun, and zif268, but not cfos, are observed (Chan et al.,
1993; Cullinan et al., 1995; Lucas et al., 2008). Furthermore, it is often
assumed that neuronal stimulation will always result in cfos transcrip-
tion. However, this is not always the case. For example, substantia nigra
activity has been measured following kindled seizure induction but
corresponding changes in Fos were not observed (Labiner et al., 1993)
and there are experimental conditions where a physiological response
to HPA axis activation has been detected without corresponding
changes in Fos expression in the PVN (Brown and Sawchenko, 1997;
Figueiredo et al., 2003). The presence or absence of changes in Fos can
depend on many factors, including whether mRNA or protein levels are
being examined. Traditionally, it is assumed that changes in mRNA will
always lead to changes in protein expression. However, there are
multiple factors that can inﬂuence protein expression including, but not
limited to, post-transcriptional modiﬁcations, ineﬃcient translation,
rapid mRNA decay or protein degradation and therefore changes in cfos
mRNA are not always consistent with levels of Fos protein expression
(Hisanaga et al., 1992; Kiessling et al., 1993; Worley et al., 1993). Fos
activation only occurs upon pronounced cellular stimulation activation,
which accounts for its low basal level of expression in most, but not all,
brain regions (Kovács, 2008). Because of this requirement for a robust
stimulation, Fos imaging is unlikely to capture subtle changes in neu-
ronal activation in response to weaker “subthreshold” stimuli.
One of the most common approaches for analyzing Fos expression is
cell counting. This approach is dependent on low basal levels of Fos and
requires expression within a given cell reaching a detection threshold in
order to produce a signal. In using this approach, Fos imaging primarily
gives an on/oﬀ signal and does not provide information about the
magnitude of expression within a cell. Thus, if experimental manip-
ulations result in the same number of neurons being activated, but Fos
levels within the cell change, the eﬀect will not be captured by cell
counting. An alternative approach is a densitometric analysis in which
the overall magnitude of the Fos response within a brain region is
measured and provides information about changes in levels of mRNA or
protein expression. However, if changes in the relevant neurocircuitry
only require a small number of neurons, these changes may still not be
captured even with densitometric analysis. For example, Liu et al.
(2014) discovered that only 5–6% of neurons in the dorsal striatum
were activated following an acute methamphetamine injection. Me-
thamphetamine induced a 3–20-fold increase in IEG levels in Fos-ex-
pressing neurons that were separated via ﬂuorescence-activated cell
sorting (FACS). However, IEG expression was 10-fold lower or un-
detectable when assessed in unsorted samples. Under these types of
conditions, even a densitometric analysis would be unlikely to capture
those relevant changes using traditional Fos imaging approaches. A
more accurate assessment of mRNA and protein expression changes
typically require using a more quantitative approach such as qPCR, for
mRNA, and western blotting, for protein, though these approaches lack
the spatial resolution as they require bulk tissue dissection. Taken to-
gether, a failure of an experiment to inﬂuence Fos expression may be a
consequence of several interacting factors and it is necessary to be
cautious when interpreting null ﬁndings.
In addition to identifying the best approach for quantiﬁcation of Fos
expression for a given experiment, it is important to include the correct
controls. Studies examining Fos expression following a behavior, should
include proper behavioral control groups to accurately determine the
speciﬁcity of the observed Fos expression patterns to the behavior of
interest. Behavioral control groups should closely match the conditions
of the experimental group to limit diﬀerences to factors other than the
experimental manipulation. For example, experiments examining
changes in Fos expression following stressor-induced reinstatement in
animals with a history of drug self-administration should include con-
trol groups of animals that have been surgically implanted with venous
catheters and are provided access to saline for self-administration or
received yoked saline/vehicle infusions prior to testing for drug
seeking. These groups control for eﬀects of a history of surgery/re-
covery, repeated infusions, and/or continual exposure to the drug
context and associated discrete cues. Such control conditions also
permit assessment of the eﬀects of an acute stressor on Fos under
conditions where reinstatement is not observed, thus allowing for
identiﬁcation of expression patterns unique to stressor-induced drug-
seeking behavior.
Beyond behavioral control groups, there are other measures to
consider in the design, execution and analysis of a Fos imaging ex-
periment. Typically, when performing in situ hybridization or im-
munohistochemistry in a brain region, it is important to take series of
sections that uniformly span the anterior/posterior (A/P) axis of that
brain region. This is important as some studies have identiﬁed diﬀer-
ential Fos staining patterns along the A/P axis of structures following
drug-seeking behavior (Mahler and Aston-Jones, 2012). In addition, in
larger experiments where it is not possible for all sections to be labeled
in a single “run,” it is important to account for potential variability
across batches of labeled tissue. This can be accomplished by ensuring
that each batch of sections contains at least one sample from each group
so that any variability across batches is not biased towards any parti-
cular experimental group.
When using cell count analyses to quantify Fos expression, data are
typically presented as either total Fos-immunoreactive (ir) cells or Fos-
ir cells/mm2. Both are valid approaches. However, presenting Fos ex-
pression as Fos/mm2 allows for better direct comparison across brain
regions with diﬀerent areas. When using a densitometric analysis, the
intensity of the signal is the critical measure, so a background signal
subtraction method should be used with a clear deﬁnition of the
parameters reported. Additionally, in all instances, a clear deﬁnition of
the boundaries for the subregions being targeted for analysis should be
reported to ensure reproducibility and allow for comparison across
studies. For any quantiﬁcation of Fos expression, the analysis may be
best served by a comparison of Fos staining within the target brain
region to a control region unlikely to show changes in Fos to provide
more deﬁnitive evidence of the speciﬁcity of the pattern of expression
to the relevant behavior. Finally, as most Fos studies report a single
value for each animal, it is important to be clear about how that value
was obtained. For example, when there is no gradient along the A/P
axis, values may be obtained by averaging densities or counts between
hemispheres within a slice, and then possibly averaging those values
across multiple sections. This minimizes the likelihood that aberrant
values in any individual section from a brain will skew results.
Interpreting a change in Fos expression also requires caution, and it
is important to consider the nature of the neuronal activation identiﬁed
by Fos, as it may not reﬂect plasticity relevant to behavior. For ex-
ample, recent work examining neuronal ensembles suggests that many
behaviors are mediated by as few as 3% of neurons in a given brain
region (Bossert et al., 2011; Cruz et al., 2014). Furthermore, these ac-
tivated neuronal ensembles may exhibit selective changes in plasticity
which are unlikely to be identiﬁed using traditional approaches.
Whitaker et al. (2017) found that food self-administration resulted in
increased intrinsic excitability in Fos-expressing neurons in the pre-
limbic cortex and decreased excitability in non-Fos expressing neurons
via distinct mechanisms. Notably, there are other IEGs that may better
reﬂect plasticity relevant for behavior. One such IEG is arc. The protein
product of arc has a demonstrated functional role in synaptic plasticity
J.R. McReynolds et al. Neurobiology of Stress xxx (xxxx) xxx–xxx
8
(Guzowski et al., 2000; Messaoudi et al., 2007) and has been implicated
in several cognitive and learning and memory related processes
(Guzowski et al., 2000; McIntyre et al., 2005).
Fos imaging approaches, as they have been traditionally used, do
not provide information about the ﬁne tuning of circuits, shifts in ﬁring
patterns (e.g. tonic to phasic), or changes in the “signal-to-noise” ratio.
Notably, in the locus coeruleus (LC), Fos expression is triggered by
induction of either phasic or tonic ﬁring (Grant et al., 1992). Thus, a
shift in the LC ﬁring pattern from phasic to tonic or vice versa would
not be reﬂected by Fos expression. Similarly, examining Fos expression
is unlikely to capture “signal-to-noise” shifts in phasic dopamine release
such as those that emerge in response to repeated administration of
drugs of abuse (see e.g., Wanat et al., 2009). An important theory of
how changes in dopamine ﬁring determine drug seeking posits that the
phasic dopamine “signal” elicited by drug-associated cues becomes
progressively more salient following repeated drug use in part due to
attenuation of the tonic “noise” pattern of ﬁring. As both tonic and
phasic activity are associated with the Fos expression, such shifts in
ﬁring patterns are unlikely to be captured using Fos-based approaches.
Fos imaging also has poor temporal resolution. Each measurement
can only represent a single time point following behavior. Thus, this
approach provides the most accurate information when Fos imaging is
conducted following a discrete experimental manipulation that occurs
within a well-deﬁned time window. However, when Fos expression is
examined following more prolonged periods of experimental manip-
ulation, such as those associated with reinstatement, the Fos signal
represents at best a rough approximation of neuronal activation as it
relates to the experimental time-point of interest (e.g., activity at the
start of the reinstatement test session). Interpretation is further com-
plicated by the likelihood that there are some cell populations that are
activated in response to the onset of stress, while the activation of other
cells may signal stressor termination (Holly and Miczek, 2016;
Navratilova et al., 2012; Tanimoto et al., 2004). Furthermore, reliance
on a single time point means that there is no pre-experimental measure
of basal Fos levels. As a result, comparison of neuronal activation pat-
terns must occur across subjects which can increase experimental
variability.
In addition, unlike in vivo electrophysiology and newer in vivo
imaging approaches, Fos does not provide real-time assessment of
changes in neuronal activity, although it can provide information about
changes in a cell type- and pathway-speciﬁc manner. Nevertheless,
when examining Fos expression independent of co-localization studies,
it is important to remember that Fos is expressed in multiple cell types
and thus it is not feasible to make conclusions about the cell types or
pathways driving the changes in Fos or the connectivity of activated
neurons. For example, the activation of GABAergic interneurons in a
brain region would produce a positive Fos signal that would likely be
associated with an overall inhibition of neuronal outputs from that
structure. Even when co-localizing Fos with retrograde tracers, there is
still a limitation to the number of pathways that can be examined in a
single brain. In sum, Fos imaging is an incredibly useful tool, in so far as
the caveats and limitations are taken into consideration. Newer ap-
proaches to analyzing Fos expression and the development of novel
technology using the cfos promotor may mitigate some of the limita-
tions of the traditional Fos imaging approach.
8. Novel approaches in using Fos signaling
8.1. Towards a “whole-brain” approach to Fos analysis
In spite of the caveats noted in the previous section, there are sev-
eral new ways to incorporate Fos analysis into behavioral neuroscience
research. Automation of image acquisition and cell counting permit
investigators to move from investigations of a small set of regions of
interest (ROIs) to a whole-brain approach to Fos analysis.
Quantiﬁcation of Fos across a wide range of ROIs can inform how
treatments inﬂuence the function of macroscale networks, in a way that
is similar to the whole-brain analyses used in functional magnetic
imaging (fMRI). One straightforward approach is to expand Fos quan-
tiﬁcation to a set of structures that have known anatomical relation-
ships and compute correlation coeﬃcients between pairs of nodes to
generate hypotheses about the function of these pathways in relation-
ship to behavior. For example, George et al. (2012) quantiﬁed Fos in
ROIs within the prefrontal cortex (PFC), amygdala and hippocampus of
alcohol dependent rats. Withdrawal from alcohol was associated with a
decrease in correlated activity between the mPFC and the CeA sug-
gesting that alcohol use and abstinence may speciﬁcally modify this
segment of the neural circuit that controls alcohol consumption (George
and Hope, 2017). The Fos results in this example provide a reliable
foundation and justiﬁcation for conducting riskier tract-speciﬁc me-
chanistic experiments to test the involvement of the circuit model in
vivo.
8.2. Graph theory-based network analysis
In the example provided above, pair-wise correlations proved to be
informative, but the statistical approach did not push the limits of the
multivariate statistical approaches that would enable inferences to be
drawn from the relationships between Fos across all of the ROIs. The
adoption of graph theory-based computational methods over the last
several years has led to major advances in understanding how networks
within the brain interact as correlates of behavior, cognition and dis-
ease (Bullmore and Sporns, 2009). Here the term graph refers to ab-
stract representation of the organization of nodes within a network and
the nature of their connections, called edges. Nodes are typically ana-
tomically deﬁned ROIs while edges may be functional, structural, or ef-
fective. Functional connectivity between regions exists when neuronal
activity in an ROI or a community, a subnetwork of interconnected
network nodes, reliably predicts activity in another ROI, ROIs, or
communities. Anatomical, or “connectome” data can be used to inform
the structural connectivity among ROIs and complement functional in-
ferences. Ideally, functional and structural connectivity provide a fra-
mework for investigating the mechanisms by which activity in one
community inﬂuences the other, called eﬀective connectivity. For more
detailed description of the network parameters and underlying com-
putations that can be evaluated with graph theoretical analysis we refer
readers to (Rubinov and Sporns, 2010). Graph theoretical analyses are
well suited for quantifying components of abstract networks such as the
large, multidimensional time-series datasets involved in human neu-
roimaging studies (Bassett and Sporns, 2017). However, Graph analyses
are useful with static data such as social media networks and so can be
applied to Fos.
As reviewed above, Fos has been used extensively as a dependent
measure in stress research with the vast majority of investigations
quantifying Fos in a small set of hypothetically signiﬁcant ROIs. These
studies led to the neural circuit model of stress and drug seeking ar-
ticulated in Section 4 in which stressor-induced drug seeking is thought
to be a consequence of the interactions of specialized brain networks.
As the ﬁeld moves to test and expand the circuity of stress and SUDs, we
believe graph theory provides a set of tools that can be applied to neural
circuit analysis to generate computational models and hypotheses about
speciﬁc functions of ROIs and networks. Graph theory was recently
applied to a simple fear conditioning experiment which we believe il-
lustrates how well large-scale Fos analysis can set the stage for ex-
pansion of our network models. Fos was quantiﬁed in 84 ROIs from
mice given fear recall test either 1 or 36 days after context-shock
conditioning (Wheeler et al., 2013). The recall test evoked strikingly
diﬀerent patterns of network activation, and importantly, diﬀerent
roles for key network nodes as a function of recall time. Following on
this initial account, Vetere et al. (2017) ﬁrst used a computational
model to simulate the eﬀect of “lesioning” nodes with high functional
connectivity on network organization. The model predicted a linear
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relationship between node connectivity and importance to in vivo fear
consolidation which was tested in vivo with node-speciﬁc chemogenetic
silencing in later behavioral experiments. The results found, unequi-
vocally, that silencing of higher degree nodes, such as the CA1 hippo-
campal region, produced the most robust interference with fear con-
solidation while silencing low degree nodes, such as medial dorsal
thalamus had eﬀect. While these results are consistent with prior in-
vestigations of fear consolidation, the computational model enabled
novel discoveries. Speciﬁcally, silencing the lateral septal nucleus or the
laterodosal thalamic nucleus, regions never implicated previously in
fear consolidation, produced marked impairments in fear recall con-
sistent with their high degree of functional connectivity. To summarize,
ROIs identiﬁed as putatively critical with graph analysis of Fos im-
munoreactivity were indeed needed for consolidation of fear memory;
importantly, many of these structures had not previously been con-
sidered important for this process and so the approach led to a sig-
niﬁcant advance in understanding.
Another appealing application of Graph theory to brain wide Fos
immunoreactivity is to describe how networks implicated in behavioral
or cognitive control interact. For example, Graph theory would allow a
holistic test, and expansion, of the prevailing model that HPA axis (i.e.,
PVN and its excitatory inputs) and reward circuits (i.e., mesocortico-
limbic DA) interact to control drug-seeking behaviors. Functionally
connected subsets of ROIs exhibit “small-world” organization (Sporns,
2013) which facilitates local computation. Small worlds communicate
with other and the global network through specialized nodes, termed
“hubs.” In the context of stressor-induced relapse, structures like the
VTA and BNST are likely to serve as hubs because of the established role
in both drug reward and stressor reactivity. Graph theory-based ana-
lyses of the stressed brain would identify tracts for hypothesis-based,
model driven, intersectional (i.e. tract speciﬁc interventions) studies
that link functional subnetworks to speciﬁc behavioral or biological
phenomena which can clarify many of the open questions noted above.
This method was recently applied in the Christianson lab to test how
exposure to stressful social stimuli inﬂuences functional connectivity of
emotional and cortical structures with an anatomically deﬁned social
decision-making network. The analysis revealed that exposure to
stressed conspeciﬁcs led to increased functional connectivity in sub-
networks consisting of structures previously ascribed to social decision
making (O'Connell and Hofmann, 2012) and socioemotional processes
(Adolphs, 2009). A few ROIs appeared to be hubs between the sub-
networks (e.g., prelimbic prefrontal cortex, insular cortex, and bed
nucleus of the stria terminals) and exposure to stressed conspeciﬁcs
altered how the subnetworks interacted (Rogers-Carter et al., 2018).
Speciﬁcally, upon exposure to stressed stimuli there were far more
functionally connected ROIs than after exposure to naive stimuli; the
interpretation is that greater network integration is an important fea-
ture of the neural basis for social stress transmission. These two illus-
trations mirror a major theme in stress research which is to understand
how the brain response to acute stressors changes as a consequence of
stress chronicity or interaction with drugs of abuse. In light of the
neural circuitry of stress and drug seeking summarized in Fig. 1, one
can imagine taking a similar approach to investigating brain-wide
network activity after diﬀerent components of drug self-administration
and reinstatement procedures to more completely describe how stres-
sors change the way drugs of abuse are processed centrally. Graph
theoretical analysis of brain wide connectivity patterns at times of
stressor-induced reinstatement, for example, will both test existing
ideas about neural control of this phenomenon but also identify new
directions for investigation in the form of novel ROIs and circuits that
could be targeted for therapeutic development.
8.3. Genetic tools using the cfos promoter
Most of the traditional Fos imaging approaches have required that
brain tissue be ﬁxed and have involved identiﬁcation of activated
neurons through in situ hybridization or immunohistochemical ap-
proaches. More recently, a series of transgenic cfos ﬂuorescent reporter
rodent lines have been established. These lines capitalize on the discrete
activation of the cfos promoter to express eﬀector proteins such as
EGFP, enhanced green ﬂuorescent protein, or β-galactosidase (β-gal),
from the lacZ gene, in strongly activated neurons. The expression of
eﬀector proteins lasts for several hours and can then be used as markers
of activated neurons for ex vivo electrophysiology or ﬂuorescent-acti-
vated cell sorting (FACS) followed by PCR or high throughput se-
quencing (Cruz et al., 2015, 2013; Lobo, 2009). The presence of these
tags allows for the comparison of Fos-expressing and non-Fos expres-
sing neurons which permits subsequent examination of patterns of gene
expression or synaptic activity changes in neuronal subpopulations
based on whether or not they were activated by an earlier experimental
manipulation. Interestingly, there are now also transgenic mice that
express an axon-targeted β-gal reporter under control of the cfos pro-
moter which allows for identiﬁcation of downstream projection ﬁelds of
activated (Fos-expressing) neuronal populations (Wilson et al., 2002).
More recently, researchers have leveraged the availability of Fos-
LacZ transgenic rodent models to functionally regulate cell populations
based on their activation patterns, as deﬁned by Fos expression. Using
this approach, the drug Daun02 is administered following exposure to
an experimental manipulation (e.g., behavioral testing). During testing
in Fos-LacZ rats, strongly activated neurons will express β-gal, and, in
those neurons, Daun02 will be converted by β-gal to its active product,
daunorubicin, which will produce apoptotic cell death (Cruz et al.,
2013). As a result, neuronal ensembles that are activated during testing
will no longer be functional and their role in behavior can determined
upon subsequent testing. Thus, these approaches not only have the
capacity to provide a representation of activation patterns that may
encode stress and other stimuli, but they permit assessment of the
functional relevance of these neuronal populations. One of the sur-
prising ﬁndings from these studies is that as few as 3–12% of neurons in
a given brain region (deﬁned by the Fos response) may be activated and
relevant for context-induced reinstatement of heroin seeking (Bossert
et al., 2011; Cruz et al., 2014; Fanous et al., 2012). The ensembles are
highly speciﬁc as silencing of the neurons in the nucleus accumbens
shell activated by a cocaine-associated context attenuates later context-
induced reinstatement of cocaine seeking. However, silencing of a si-
milar number of neurons within the nucleus accumbens shell that are
activated by a novel non-associated context has no eﬀect on cocaine-
seeking behavior (Cruz et al., 2014). This is likewise supported by
ﬁndings that there are non-overlapping ensembles in the vmPFC for
contexts speciﬁcally associated with heroin SA or extinction such that
silencing of heroin context ensembles, but not extinction context en-
sembles, attenuates context-induced heroin seeking (Bossert et al.,
2011). Furthermore, studies using this approach suggest that drug-as-
sociated context and cues may activate diﬀerent patterns of Fos-ex-
pressing neurons (Cruz et al., 2015). These studies have identiﬁed novel
roles for brain regions in cocaine-seeking behavior and continue to
promote re-evaluation of relevant neurocircuitry. To date this approach
has not been used to assess stressor-induced drug seeking.
Unfortunately, expression of β-gal or EGFP in these transgenic
models is transient, only lasting hours. To address this limitation,
TetTag mice have been developed with the goal of tagging activated
neurons with a longer-lasting signal. In this model, a tetracycline
transactivator (tTA) is expressed under the control of the cfos promoter,
but its expression is inhibited in the presence of doxycycline (Dox). A
second construct encodes a reporter, such as LacZ, under the control of
the tetO promoter, and is not expressed in the presence of Dox.
However, in the absence of Dox, strong neuronal activity drives tTA
expression which then binds to a tetracycline response element (TRE),
that contains the tetO sequence, to induce LacZ expression. Dox is ty-
pically provided in the animal's food and the Dox-containing chow is
taken away prior to the experimental manipulation (e.g., reinstatement
testing) and returned to the animal following completion of the
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behavioral paradigm. As a result, tTA-driven LacZ expression is limited
to neurons strongly activated only in the period in which mice were
Dox-free (Reijmers and Mayford, 2009). This signal is longer lasting
because the LacZ construct contains a transcriptional feedbook loop
that maintains gene expression even in the presence of Dox through the
inclusion of a mutant tTA that is Dox-insensitive. A newer version of the
Tet Tag approach uses tTA-driven expression of a histone H2B-EGFP
fusion protein under the control of the cfos promoter that produces a
longer-lasting signal in activated neurons that takes several weeks to
degrade (Tayler et al., 2013, 2011). A major advantage of this approach
is the ability to examine neuronal activation patterns several days to
weeks after they occur. Thus, it is possible to expose animals to a second
experimental manipulation, or re-expose to the ﬁrst manipulation, and
examine co-localization of LacZ or EGFP expression with another IEG.
For example, this technique has been used to examine reactivation of
the circuits engaged during learning in a subsequent memory retrieval
test (Reijmers et al., 2007). While potentially powerful, these techni-
ques have been somewhat limited by the long window of opportunity
for neuronal labeling such that background levels of expression can be
high. As a result, the induction of the reporter in these studies has only
been ∼2–4 fold higher than home cage controls (DeNardo and Luo,
2017). Using the Fos promoter to introduce ﬂuorescent transgenes
opens the possibility of ex vivo experiments in which populations of
tagged neurons are compared to untagged neurons. This was ﬁrst de-
monstrated with the fosGFP mouse (Barth et al., 2004). In this experi-
ment, cfos-driven GFP-expressing neurons were targeted using whole-
cell recordings, thus permitting characterization of intrinsic, synaptic
and circuit properties of neurons that comprised a behaviorally relevant
ensemble. In principle, this type of approach should extend to Fos based
cell-sorting, Fos based laser capture and dissection, and Fos based
single-cell genomics; to our knowledge these have not yet been re-
ported.
Recent innovations have combined the TetTag mouse lines with
viral delivery of optogenetic or chemogenetic receptors downstream of
the TRE sequence to permit functional manipulation of Fos-deﬁned
neuronal ensembles (Garner et al., 2012; Liu et al., 2012; Ramirez et al.,
2015, 2013). Furthermore, the TetTag mouse lines have also been
combined with the translating ribosome aﬃnity puriﬁcation (TRAP)
method that produces tTA-driven expression of the EGFP-tagged ribo-
somal protein L10a under the control of the Fos promoter to isolate and
identify actively translating mRNAs in activated neuronal populations
(Drane et al., 2014). Lastly, a newer technique to functionally manip-
ulate transiently activated neuronal populations involves diﬀerent
TRAP (Targeted Recombination in Active Populations) mouse lines
wherein one transgene expresses a tamoxifen-dependent recombinase,
CreERT2, under the control of the cfos promoter, and a second transgene
or virus expresses a Cre-dependent eﬀector protein (Guenthner et al.,
2013). In these mouse models, Cre recombinase is only expressed in
strongly activated neurons and recombination only occurs in the pre-
sence of tamoxifen. Therefore, it is possible to obtain constitutive ex-
pression of an eﬀector protein in neuronal populations activated during
an experimental window (Kawashima et al., 2014). However, it should
be noted that tamoxifen is a selective estrogen receptor modulator
which may be problematic for studies investigating drug-seeking, par-
ticularly in female rodents, as estrogen facilitates drug-seeking behavior
(Anker and Carroll, 2011; Doncheck et al., 2018). Recently, Sørensen
et al. (2016) introduced a synthetic Fos promoter which has very low
background activity, resulting in improved sensitivity of tTA to dox-
ycycline. This method, termed RAM (Robust Activity Marking), is also
compatible with adeno-associated virus (AAV) gene transfer, and
therefore enables targeting of neuronal ensembles in non-murine
models, including rats.
The activity-dependent targeting technologies mentioned above are
also enhanced by the development of intersectional/combinatorial ge-
netic/viral strategies. The development of cell-type speciﬁc Cre re-
combinase expression through viral delivery or genetic mouse and rat
Cre lines has enabled researchers to examine and manipulate cell type-
speciﬁc subpopulations of activated neurons (Allen and Luo, 2015;
Huang and Zeng, 2013; Madisen et al., 2015). In addition, newer
viruses have been identiﬁed/produced to enable retrograde delivery of
Cre recombinase which allows for pathway-speciﬁc expression of ge-
netic tools to manipulate neural circuits or label activated neurons
(Junyent and Kremer, 2015; Tervo et al., 2016). Furthermore, these
techniques continue to evolve beyond the cfos promoter. For example, a
newer synthetic promoter has been developed, enhanced synaptic ac-
tivity-responsive element (E-SARE), that may provide greater sensi-
tivity over models using the Fos promoter (Kawashima et al., 2013). In
addition, newer approaches, such as the FLARE technique, have re-
solved some issues with the long labeling window associated with tra-
ditional TetTag methods that require doxycycline. In this approach, a
novel transcription factor is activated only in the presence of coincident
increases in intracellular Ca2+, indicating neuronal activation, and blue
light administration through a ﬁber optic cannula, theoretically lim-
iting activation of the transcription factor to a more discrete deﬁned
period. The transcription factor can then drive expression of a reporter
signal such as mCherry, to tag activated neurons, or expression of op-
sins to later functionally manipulate the activated circuits (Wang et al.,
2017). As activity-dependent targeting technologies continue to be re-
ﬁned, neuroscientists will gain an increasingly powerful set of tools to
i.) quantify how stress and drug exposure alter activation patterns of
selective neuronal ensembles, ii.) determine how they aﬀect cellular
and circuit physiology and iii.) manipulate activity-labeled neuronal
populations to provide mechanistic insight to their behavioral re-
levance.
9. Summary
Here we review the current understanding of the neural circuitry
through which stressors promote relapse to drug use. More work is
needed to identify patterns of neuronal activation within relevant brain
regions and pathways in preclinical models of stressor-induced relapse.
Toward this end, Fos imaging-based approaches can provide useful
tools for the identiﬁcation of speciﬁc patterns of activation, as long as
the caveats and limitations of these approaches are understood and
taken into consideration. The combination of traditional Fos imaging
approaches, computational and genetic techniques, and in vivo imaging
techniques, such as calcium imaging, should provide critical informa-
tion about the neurobiological mechanisms that mediate stressor-in-
duced relapse and therefore inform and/or guide the development of
therapeutic interventions and strategies for the management of SUDs.
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